Manhattan Scientifics Inc. Issues Shareholder Update on its Nano-Metals Technology

December 12, 2018

NEW YORK--Manhattan Scientifics Inc., today announced that the company is involved in discussions to license its nano-metals technology and related intellectual property to a medical industry metals manufacturer.

Manhattan Scientifics has to date received $500,000 good faith and machinery payments from the sale of equipment to the manufacturer.

Discussions with this manufacturer have been on-going for an extended period. The closing of such agreement is subject to continued due diligence, drafting a definitive agreement and approval of our Board of Directors. There can be no guarantee that we will satisfactorily conclude a commercial arrangement with this manufacturer.

About Manhattan Scientifics

Manhattan Scientifics Inc. ( is focused on commercialization of disruptive technologies in the nano medicine space.

Forward-looking statement

This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.